FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386098635> ?p ?o ?g. }

• W4386098635 abstract "Background: Many patients with Parkinson’s disease (PD) experience action tremor (including postural and kinetic tremors) that impair activities of daily living. Transcutaneous afferent patterned stimulation (TAPS) is a non-invasive neuromodulation therapy that modulates tremorgenic activity at the ventral intermediate nucleus (VIM). Most TAPS evidence evaluated relief of action tremor associated with essential tremor (ET). This study evaluated whether TAPS results in similar relief of action tremor associated with PD. Methods: Forty PD patients with action tremors were enrolled in a prospective, single-arm, open-label study with four weeks of unsupervised at-home TAPS sessions in the dominant hand twice daily in between supervised TAPS sessions at two telemedicine appointments. The primary endpoint was change in tremor power as measured by the on-board accelerometer before and immediately after a stimulation session. Additional study endpoints included change in Movement Disorder Society-Sponsored Unified Parkinson’s Disease Rating Scale Part III (MDS-UPDRS), change in Bain and Findley Activities of Daily Living (BF-ADL) scale, and clinician and patient global impressions of improvement (CGI-I and PGI-I). Results: TAPS reduced tremor power by 64% (54%–79%) (median (interquartile range), p < 0.001), with 79% of patients experiencing at least 50% reduction. When comparing pre-stimulation scores at visit 1 to post-stimulation scores at visit 2, TAPS improved per-task MDS-UPDRS III ratings of postural and kinetic tremors (0.6 ± 0.5, t(34) = 7.05, p < 0.001) and per-task patient-ratings of BF-ADL ADL upper limb motion ratings (0.5 ± 0.5, t(34) = 5.69, p < 0.001). Clinicians reported improvement in 78–83% of patients and 75–80% of patients reported improvement. Adverse events, most commonly skin reaction at the stimulation site, occurred in 18% of patients. Conclusion: Objective, clinician-rated, and patient-rated assessments demonstrated that TAPS provided clinically meaningful relief of action tremor in patients with PD." @default.
• W4386098635 created "2023-08-24" @default.
• W4386098635 creator A5009117789 @default.
• W4386098635 creator A5013627398 @default.
• W4386098635 creator A5017602194 @default.
• W4386098635 creator A5020248160 @default.
• W4386098635 creator A5060500557 @default.
• W4386098635 creator A5060664922 @default.
• W4386098635 creator A5061001628 @default.
• W4386098635 creator A5091547171 @default.
• W4386098635 creator A5092680847 @default.
• W4386098635 date "2023-01-01" @default.
• W4386098635 modified "2023-10-01" @default.
• W4386098635 title "Non-Invasive Transcutaneous Afferent Patterned Stimulation Therapy Offers Action Tremor Relief in Parkinson&rsquo;s Disease" @default.
• W4386098635 cites W1742833546 @default.
• W4386098635 cites W1971255930 @default.
• W4386098635 cites W1991939322 @default.
• W4386098635 cites W1994712141 @default.
• W4386098635 cites W1999702935 @default.
• W4386098635 cites W2040011156 @default.
• W4386098635 cites W2068457088 @default.
• W4386098635 cites W2074037165 @default.
• W4386098635 cites W2081376098 @default.
• W4386098635 cites W2090385874 @default.
• W4386098635 cites W2125011316 @default.
• W4386098635 cites W2148764702 @default.
• W4386098635 cites W2191082636 @default.
• W4386098635 cites W2406430691 @default.
• W4386098635 cites W2475994463 @default.
• W4386098635 cites W2772897268 @default.
• W4386098635 cites W2773390988 @default.
• W4386098635 cites W2791109232 @default.
• W4386098635 cites W2793390293 @default.
• W4386098635 cites W2794038637 @default.
• W4386098635 cites W2801481394 @default.
• W4386098635 cites W2884924428 @default.
• W4386098635 cites W2912707482 @default.
• W4386098635 cites W2913764457 @default.
• W4386098635 cites W3036571862 @default.
• W4386098635 cites W3049582893 @default.
• W4386098635 cites W3105342897 @default.
• W4386098635 cites W3110795665 @default.
• W4386098635 cites W380126523 @default.
• W4386098635 cites W4294030730 @default.
• W4386098635 doi "https://doi.org/10.5334/tohm.762" @default.
• W4386098635 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37637850" @default.
• W4386098635 hasPublicationYear "2023" @default.
• W4386098635 type Work @default.
• W4386098635 citedByCount "0" @default.
• W4386098635 crossrefType "journal-article" @default.
• W4386098635 hasAuthorship W4386098635A5009117789 @default.
• W4386098635 hasAuthorship W4386098635A5013627398 @default.
• W4386098635 hasAuthorship W4386098635A5017602194 @default.
• W4386098635 hasAuthorship W4386098635A5020248160 @default.
• W4386098635 hasAuthorship W4386098635A5060500557 @default.
• W4386098635 hasAuthorship W4386098635A5060664922 @default.
• W4386098635 hasAuthorship W4386098635A5061001628 @default.
• W4386098635 hasAuthorship W4386098635A5091547171 @default.
• W4386098635 hasAuthorship W4386098635A5092680847 @default.
• W4386098635 hasBestOaLocation W43860986351 @default.
• W4386098635 hasConcept C126322002 @default.
• W4386098635 hasConcept C138496976 @default.
• W4386098635 hasConcept C14184104 @default.
• W4386098635 hasConcept C15744967 @default.
• W4386098635 hasConcept C1862650 @default.
• W4386098635 hasConcept C24998067 @default.
• W4386098635 hasConcept C2778261627 @default.
• W4386098635 hasConcept C2778542668 @default.
• W4386098635 hasConcept C2779134260 @default.
• W4386098635 hasConcept C2779734285 @default.
• W4386098635 hasConcept C2780112193 @default.
• W4386098635 hasConcept C71924100 @default.
• W4386098635 hasConcept C79544238 @default.
• W4386098635 hasConcept C83849319 @default.
• W4386098635 hasConcept C99508421 @default.
• W4386098635 hasConceptScore W4386098635C126322002 @default.
• W4386098635 hasConceptScore W4386098635C138496976 @default.
• W4386098635 hasConceptScore W4386098635C14184104 @default.
• W4386098635 hasConceptScore W4386098635C15744967 @default.
• W4386098635 hasConceptScore W4386098635C1862650 @default.
• W4386098635 hasConceptScore W4386098635C24998067 @default.
• W4386098635 hasConceptScore W4386098635C2778261627 @default.
• W4386098635 hasConceptScore W4386098635C2778542668 @default.
• W4386098635 hasConceptScore W4386098635C2779134260 @default.
• W4386098635 hasConceptScore W4386098635C2779734285 @default.
• W4386098635 hasConceptScore W4386098635C2780112193 @default.
• W4386098635 hasConceptScore W4386098635C71924100 @default.
• W4386098635 hasConceptScore W4386098635C79544238 @default.
• W4386098635 hasConceptScore W4386098635C83849319 @default.
• W4386098635 hasConceptScore W4386098635C99508421 @default.
• W4386098635 hasIssue "1" @default.
• W4386098635 hasLocation W43860986351 @default.
• W4386098635 hasLocation W43860986352 @default.
• W4386098635 hasOpenAccess W4386098635 @default.
• W4386098635 hasPrimaryLocation W43860986351 @default.
• W4386098635 hasRelatedWork W178081488 @default.
• W4386098635 hasRelatedWork W2012306356 @default.
• W4386098635 hasRelatedWork W2425702559 @default.
• W4386098635 hasRelatedWork W2460842794 @default.
• W4386098635 hasRelatedWork W2545430681 @default.

• next